Drug Profile
Socorromycin
Alternative Names: A 85858Latest Information Update: 05 Feb 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antibacterials; Antifungals; Macrocyclic lactams
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 25 May 1995 Suspended-Unspecified phase in Bacterial infections in USA (Unknown route)